GlassScriptPhysician profile
Sara Patterson
NPI 1285057976
$1,383.36
in general payments reported to CMS, 2019-2025
19 companies · $341 in 2025
The $341 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $494 · 2022: $206 · 2023: $159 · 2024: $184 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $455.21 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $246.58 | 2021-2025 | Airsupra, Breztri |
| Hologic INC | $134.79 | 2021 | |
| Novo Nordisk INC | $103.97 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $58.45 | 2024-2025 | Evenity, Prolia |
| Pfizer INC. | $53.85 | 2024-2025 | |
| Viatris Specialty LLC | $43.28 | 2025 | Yupelri |
| Biohaven Pharmaceutical Holding Company LTD. | $41.20 | 2022 | |
| Therapeuticsmd, INC. | $37.03 | 2021-2022 | |
| Lucid Diagnostics INC. | $36.94 | 2022 | |
| Dexcom, INC. | $25.77 | 2025 | Dexcom G6 Transmitter |
| Hologic Sales and Service, LLC | $23.99 | 2025 | Aptima, Thinprep 2000 Processor |
| Abbott Laboratories | $21.08 | 2023 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $20.31 | 2025 | Spravato |
| Lundbeck LLC | $20.13 | 2025 | Rexulti |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $17.26 | 2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $15.77 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.05 | 2024 | Eliquis |
| Exeltis, USA INC. | $12.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.